Authors and Affiliates
Mahalingam D1,2, Wilkinson GA3, Eng KH4, Fields P5, Raber P5, Moseley JL2, Cheetham K3, Coffey M3, Nuovo G6, Kalinski P4, Zhang B7, Arora SP2, Fountzilas C4;
1
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois. Mahalingam@northwestern.edu.
2
Mays Cancer Center, University of Texas Health San Antonio, San Antonio, Texas.
3
Oncolytics Biotech Inc, Calgary, Alberta, Canada.
4
Roswell Park Comprehensive Cancer Center, Buffalo, New York.
5
Adaptive Biotechnologies, Seattle, Washington.
6
Ohio State University Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.
7
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.
